FDA Approves a Diabetes Drug for Use as Aid to Weight Loss Wegovy — a high-dose version of the diabetes drug semaglutide — has been approved as a new aid to weight loss by the U.S. Food and Drug Administration. Studies funded by drug maker Novo Nordisk showed that participantsContinue Reading

MONDAY, June 7, 2021 (HealthDay News) — People hospitalized for COVID-19 are often discharged in much worse shape than before their illness — underscoring the value of preventing severe cases with vaccination. In a new study, researchers found that during the pandemic’s early months, almost half of COVID-19 patients dischargedContinue Reading

MONDAY, June 7, 2021 (HealthDay News) — Antibiotics do not reduce the risk of hospitalization or death in patients with a lethal lung disease known as idiopathic pulmonary fibrosis, a new study finds. “We were certainly disappointed in the results,” said study co-author Dr. Imre Noth, chief of pulmonary andContinue Reading